Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.
Sci Rep. 2021 Jun 23;11(1):13164. doi: 10.1038/s41598-021-92521-4.
Sci Rep. 2021.
PMID: 34162945
Free PMC article.